drugset / Trial / NCT01816295

A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy

NCT01816295 ↗

Phase 3 Completed 715 enrolled Eli Lilly and Company
RandomizedParallel-groupTriple-blindTreatment

Summary

The main purpose of this study is to evaluate if testosterone solution can raise testosterone hormone levels into the normal range, and also improve levels of sexual arousal, interest and drive and/or energy level, in men with low testosterone and decreased sexual arousal, interest and drive and/or decreased energy. The study will last about 16 weeks, followed by an optional 24 week open label treatment phase to investigate the long term safety of testosterone solution.

Timeline

Start
2013-05
Primary completion
2014-10
Completion
2015-04

Outcome

Met primary endpoint

paper 73% in the testosterone vs 15% in the placebo group had a testosterone level within the normal range at study end point (p <0.001). PMID 26498057 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 60 mg Topical

Indications